Literature DB >> 19647292

Hospital mortality due to pulmonary embolism and an evaluation of the usefulness of preventative interventions.

Dimitrios Scarvelis1, Josdalyne Anderson, Laurie Davis, Melissa Forgie, James Lee, Linn Petersson, Tim Ramsay, Philip S Wells.   

Abstract

BACKGROUND: Mortality rates due to pulmonary embolism (PE) are difficult to estimate often due to the presence of comorbid disease.
OBJECTIVES: To determine the accuracy of hospital records in identifying PE cases, PE-related mortality, and the number of PE-related deaths which are potentially preventable.
METHODS: Retrospective chart review of PE cases hospitalized at The Ottawa Hospital over an 8 year period. Cases were reviewed to determine accuracy of coding, as well as the certainty with which PE was the cause of death. In PE-related deaths, a determination was made as to whether any interventions may have been life-saving.
RESULTS: 498 cases of 612 (81%) cases coded as PE were correctly coded. 111 (22%) died during hospitalization, 63% of deaths were attributed to PE. The presence of a cardiorespiratory comorbidity or cancer was independently associated with an increased rate of death due to PE. 54% of PE-related deaths were determined to be potentially preventable, most commonly by appropriate DVT prophylaxis. A significantly higher number of cancer patients as compared to non-cancer patients may have potentially had their death due to PE prevented by an inferior vena cava filter (IVCF). Systemic thrombolysis was deemed to be potentially life-saving in 1/38 PE-related deaths.
CONCLUSION: Hospital mortality due to clinically recognized PE can be determined by chart review of PE cases identified using the ICD coding system. Death due to PE is often potentially preventable; in the subgroup with cancer and DVT/PE, an IVCF may be a potentially useful intervention to prevent death due to PE. Prospective studies are needed to confirm these results. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19647292     DOI: 10.1016/j.thromres.2009.06.025

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

Review 1.  Thrombosis and cancer.

Authors:  Annie Young; Oliver Chapman; Carole Connor; Christopher Poole; Peter Rose; Ajay K Kakkar
Journal:  Nat Rev Clin Oncol       Date:  2012-07-10       Impact factor: 66.675

2.  Perfusion SPECT in patients with suspected pulmonary embolism: how much sensitivity is needed to keep patients alive?

Authors:  Carl Schuemichen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09       Impact factor: 9.236

Review 3.  Mechanisms and biomarkers of cancer-associated thrombosis.

Authors:  Ann S Kim; Alok A Khorana; Keith R McCrae
Journal:  Transl Res       Date:  2020-07-06       Impact factor: 7.012

4.  Limitations of pulmonary embolism ICD-10 codes in emergency department administrative data: let the buyer beware.

Authors:  Kristin Burles; Grant Innes; Kevin Senior; Eddy Lang; Andrew McRae
Journal:  BMC Med Res Methodol       Date:  2017-06-08       Impact factor: 4.615

5.  [Risk factors and prognosis of lung cancer combined with pulmonary embolism].

Authors:  Jun Wang; Weihua Zhou; Lin Xu; Min Yang; Lijuan Meng; Weifei Fan; Xiaolin Pu; Yuanhua Yang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.